# Gabapentin for Postop Pain After SSLF

> **NCT03123861** · PHASE4 · COMPLETED · sponsor: **University of North Carolina, Chapel Hill** · enrollment: 45 (actual)

## Conditions studied

- Pelvic Organ Prolapse

## Interventions

- **DRUG:** Gabapentin
- **DRUG:** Placebo oral capsule

## Key facts

- **NCT ID:** NCT03123861
- **Lead sponsor:** University of North Carolina, Chapel Hill
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-06-01
- **Primary completion:** 2020-07-25
- **Final completion:** 2020-07-25
- **Target enrollment:** 45 (ACTUAL)
- **Last updated:** 2020-10-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03123861

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03123861, "Gabapentin for Postop Pain After SSLF". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT03123861. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*